October 3 | 2018

Add. info to newsletter ”2cureX GmbH receives contribution for the development of IndiTreat® tests in immuno-oncology”

Read more
September 12 | 2018

Meet us at Sedermeradagen in Göteborg

Read more
August 24 | 2018

2cureX AB publishes interim report for the first half-year of 2018

Read more
August 22 | 2018

2cureX strengthen its patent portfolio with the granting of a new European patent

Read more
July 26 | 2018

Meet us at LSX Nordic Congress

Read more
July 20 | 2018

2cureX continues to update its frequently asked Question page on www.2curex.com

Read more
June 21 | 2018

2cureX presents positive clinical data from its IndiTreat® CRC trial at ESMO in Barcelona

Read more
May 29 | 2018

Clarification of warrants resolved at the Annual General Meeting

Read more
May 24 | 2018

The University Hospital, Rigshospitalet, University Medical Center Hamburg-Eppendorf and 2cureX have initiated a clinical study in ovarian cancer

Read more
May 18 | 2018

2cureX AB publishes interim report for the first financial quarter of 2018

Read more
May 7 | 2018

2cureX AB publishes annual report for the fiscal year 2017

Read more
May 4 | 2018

2cureX releases new information brochure

Read more
May 2 | 2018

2cureX’s CEO Ole Thastrup will join Folkemødet 2018 in Denmark

Read more
April 24 | 2018

2cureX is expanding its operations in Germany with the opening of a screening lab at Centrum für innovative Medizin (CiM), Hamburg

Read more
March 13 | 2018

2cureX receives first payment of EUR 1,5 million from EU Horizon 2020

Read more
March 12 | 2018

2cureX invited to present IndiTreat® and clinical data at ESMO in June 2018

Read more
February 27 | 2018

2cureX will participate at Sedermeradagen Copenhagen

Read more
January 22 | 2018

2cureX agrees on final terms concerning an EUR 3 million grant from Horizon 2020

Read more